The immunotherapeutic effect of dendritic cells vaccine modified with interleukin-18 gene and tumor cell lysate on mice with pancreatic carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

398

HTML

2602

Figures (1-3)

238

Tables (1-1)

206

Sum=3444

Oct 15, 2002 (publication date) through Dec 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Oct 15, 2002; 8(5): 908-912
Published online Oct 15, 2002. doi: 10.3748/wjg.v8.i5.908

Figure 1 T cells were tested for cytolytic activity in a standard 4-h ⁵¹Cr-release assay. Effector-to target (E/T) ratio were from 20:1 to 100:1.

Figure 2 A, B The concentration of IL-18 and IFN-γ in the serum were measured by ELISA

Figure 3 The development of the transplanted tumors was observed in every day

Citation: Tang ZH, Qiu WH, Wu GS, Yang XP, Zou SQ, Qiu FZ. The immunotherapeutic effect of dendritic cells vaccine modified with interleukin-18 gene and tumor cell lysate on mice with pancreatic carcinoma. World J Gastroenterol 2002; 8(5): 908-912
URL: https://www.wjgnet.com/1007-9327/full/v8/i5/908.htm
DOI: https://dx.doi.org/10.3748/wjg.v8.i5.908